Trial Profile
Study evaluating the association of Tofacitinib, Glucocorticoid use, and Methotrexate with respect to Herpes zoster risk in patients with Rheumatoid Arthritis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 21 Nov 2018
Price :
$35
*
At a glance
- Drugs Tofacitinib (Primary) ; Glucocorticoids; Methotrexate
- Indications Rheumatoid arthritis
- Focus Adverse reactions
- 24 Oct 2018 Results (n=8030) presented at the 82nd American College of Rheumatology and the 52nd Association of Rheumatology Health Professionals Annual Scientific Meeting
- 21 Sep 2018 New trial record
- 26 Aug 2018 Results presented at the 34th International Conference on Pharmacoepidemiology and Therapeutic Risk Management